RAPT Therapeutics, Inc. (RAPT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 161.04M | 172.86M | 183.2M | 235.24M | 102.6M | 120.5M | 148.36M | 161.78M | 187.14M | 207.42M | 234.59M | 252.69M |
| Cash & Short-Term Investments | 157.34M | 168.95M | 179.28M | 231.06M | 97.91M | 114.84M | 141.58M | 158.86M | 184.78M | 205M | 231.63M | 249.07M |
| Cash Only | 37.93M | 41.89M | 60.26M | 169.74M | 37.9M | 37.08M | 45.32M | 47.48M | 54.13M | 50.16M | 45.77M | 38.95M |
| Short-Term Investments | 119.41M | 127.06M | 119.02M | 61.32M | 60.01M | 77.76M | 96.26M | 111.38M | 130.64M | 154.83M | 185.86M | 210.12M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.7M | 3.91M | 3.92M | 4.18M | 4.69M | 5.66M | 6.78M | 2.92M | 2.36M | 2.42M | 2.96M | 3.63M |
| Total Non-Current Assets | 4.69M | 5.55M | 4.37M | 5.09M | 5.87M | 6.68M | 7.46M | 11.55M | 12.58M | 13.34M | 13.74M | 13.52M |
| Property, Plant & Equipment | 2.65M | 3.28M | 3.98M | 4.7M | 5.48M | 6.24M | 7.01M | 7.68M | 8.38M | 9.07M | 9.53M | 9.48M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.05M | 2.27M | 389K | 389K | 389K | 447K | 447K | 3.87M | 4.21M | 4.27M | 4.21M | 4.04M |
| Total Assets | 165.74M | 178.41M | 187.57M | 240.32M | 108.47M | 127.18M | 155.82M | 173.33M | 199.72M | 220.76M | 248.33M | 266.21M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 52.8% | 40.28% | 20.38% | 38.65% | -45.69% | -42.39% | -37.25% | -34.89% | -4.66% | -0.56% | 32.41% | 34.02% |
| Total Current Liabilities | 13.38M | 13.04M | 8.68M | 48.35M | 10.36M | 14.8M | 21.17M | 21.84M | 21.85M | 15.41M | 21.61M | 14.22M |
| Accounts Payable | 2.1M | 4.19M | 1.29M | 1.27M | 1.38M | 2.72M | 6.77M | 5.18M | 5.3M | 2.69M | 8.94M | 3.37M |
| Days Payables Outstanding | - | 7.64K | - | - | - | - | 7.87K | - | - | - | - | - |
| Short-Term Debt | 2.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 9.06M | 3.41M | 2.83M | 6.78M | 4.93M | 4.65M | 82K | 6.41M | 5.56M | 4.07M | 3.17M | 32K |
| Current Ratio | 12.04x | 13.25x | 21.11x | 4.87x | 9.90x | 8.14x | 7.01x | 7.41x | 8.57x | 13.46x | 10.86x | 17.77x |
| Quick Ratio | 12.04x | 13.25x | 21.11x | 4.87x | 9.90x | 8.14x | 7.01x | 7.41x | 8.57x | 13.46x | 10.86x | 17.77x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 387K | 959K | 1.52M | 2.07M | 2.6M | 3.16M | 3.81M | 4.46M | 5.07M | 5.67M | 6.25M | 6.82M |
| Long-Term Debt | 387K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 959K | 1.52M | 2.07M | 2.6M | 3.16M | 3.81M | 4.46M | 5.07M | 5.67M | 6.25M | 6.82M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 13.76M | 14M | 10.2M | 50.42M | 12.96M | 17.96M | 24.98M | 26.29M | 26.92M | 21.08M | 27.86M | 21.04M |
| Total Debt | 2.6M | 3.16M | 3.83M | 4.49M | 5.12M | 5.73M | 6.32M | 6.91M | 7.46M | 8M | 8.53M | 8.99M |
| Net Debt | -35.33M | -38.72M | -56.42M | -165.24M | -32.78M | -31.35M | -38.99M | -40.57M | -46.67M | -42.17M | -37.24M | -29.96M |
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.05x | 0.05x | 0.05x | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 151.98M | 164.41M | 177.37M | 189.9M | 95.51M | 109.22M | 130.84M | 147.03M | 172.8M | 199.68M | 220.47M | 245.17M |
| Equity Growth % | 59.13% | 50.53% | 35.57% | 29.16% | -44.73% | -45.3% | -40.66% | -40.03% | -8.72% | -1.21% | 31.36% | 31.54% |
| Book Value per Share | 5.64 | 6.10 | 6.59 | 32.54 | 19.64 | 22.48 | 27.10 | 30.65 | 36.04 | 41.68 | 46.07 | 54.96 |
| Total Shareholders' Equity | 151.98M | 164.41M | 177.37M | 189.9M | 95.51M | 109.22M | 130.84M | 147.03M | 172.8M | 199.68M | 220.47M | 245.17M |
| Common Stock | 2K | 13K | 13K | 13K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
| Retained Earnings | -666.93M | -649.36M | -631.71M | -614.55M | -561.3M | -542.87M | -515.2M | -484.68M | -453.81M | -422.44M | -397.15M | -367.88M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 100K | 16K | 35K | 50K | 107K | -47K | -10K | 103K | -121K | -180K | 339K | -26K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |